Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
DOSE ADJUSTMENT OF VANCOMYCIN USING CYSTATIN C IN SEPSIS WITH BACTERIAL MENINGITIS: A CASE REPORT
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-PAA-002
- By: CHUMA, Masayuki (Tokushima University Hospital, Clinical Trial Center for Developmental Therapeutics, Japan)
- Co-author(s): Masayuki Chuma: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima , Japan
Masateru Kondo: Department of Pharmacy, Tokushima University Hospital, Tokushima , Japan
Yoshito Zamami: Department of Pharmacy, Tokushima University Hospital, Tokushima , Japan;Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima , Japan
Kenshi Takechi: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima , Japan
Mitsuhiro Goda: Department of Pharmacy, Tokushima University Hospital, Tokushima , Japan
Naoto Okada: Department of Pharmacy, Tokushima University Hospital, Tokushima , Japan
Akitomo Shibata: Department of Pharmacy, Saiseikai Kumamoto Hospital, Kumamoto, Japan
Mizuho Asada: Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan
Jun Oto: Department of Emergency and Critical Care Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima , Japan
Hiroaki Yanagawa: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima , Japan
Keisuke Ishizawa: Department of Pharmacy, Tokushima University Hospital, Tokushima , Japan;Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima , Japan - Abstract:
Background
Vancomycin (VCM) dosing needs to adjust accurately according to therapeutic drug monitoring (TDM) in bacterial meningitis. In determining VCM dosage, renal function is the most important factor. It is necessary to establish VCM dosing regimen that utilize novel marker of renal function because creatinine clearance (CrCl) may not be.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023